This directory combines historical reference rows with separately labelled national sources. Read the source title, observation date, printed units and conditions on each entry. National source observations do not establish all measures applicable to a shipment.
Egypt Customs Tariff for HS Code 300331
Medicaments; containing insulin, for therapeutic or prophylactic uses, not packaged for retail sale
The source reports an indicative HS6 MFN average of 1% for Medicaments; containing insulin, for therapeutic or prophylactic uses, not packaged for retail sale.Source status: not assessed. Verify the exact national tariff line, origin treatment, taxes, restrictions, and current customs guidance before using this information in a declaration.
Check local VAT and excise rules for the import destination.
Unit / basis
Not listed in this tariff line
Source / vintage
WITS/UNCTAD TRAINS (MFN 2019) (2019)
Historical MFN average
1%
1%
Import permission
not assessed
Egyptian Customs national subdivisions
Official lookup checked 2026-09-22. These ten-digit codes share the prefix 300331; choose the product using its national description. The historical WITS average above is not the duty of each subdivision.
The lookup supplies no line-level effective date. Origin preferences, exemptions and conditions can change the payable amount. The original Arabic descriptions, taxes and conditions are retained below; an import-duty percentage is not a total-tax calculation or an import permission.
أدوية الاورام وزراعة الاعضاء ، أدوية القلب والاوعية الدموية ، أدوية البلهارسيا ،البدائل الصناعية للبلاز مة ، ادوية الامراض المستعصية والمزمنة والنفسية والعصبية ، غير مهيأة في مقادير معايرة أو بأشكال أو في أغلفة معدة للبيع بالتجزئة ، تحتوي علي أنسولين و لا تحتوي علي مضادات حيوية .
Each destination shows its own source label. Oman uses its national schedule; Qatar and UAE entries may cite their separately published references and unresolved exceptions. Other entries retain the historical GCC reference. National codes, duty notes, restrictions and tax treatment can differ; verify with the destination customs authority.
Medicaments; containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)
Medicaments; containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)
Medicaments; containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale
Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, (not packaged for retail sale)
Medicaments; containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale)
Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
1.33333%
Data source: WITS/UNCTAD TRAINS (MFN 2019). Values are indicative HS6 MFN averages, not shipment-specific applied rates. Import permission and restrictions are not assessed. Historical reference rates exclude VAT, excise and other national measures. Separate national entries preserve the columns printed by their source; these are not a complete shipment assessment. Full disclaimer.